Agilon Health (Agilon Health) Cash And Cash Equivalents : $108 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Agilon Health Cash And Cash Equivalents?

Agilon Health's quarterly cash and cash equivalents declined from Jun. 2023 ($190.98 Mil) to Sep. 2023 ($168.34 Mil) but then stayed the same from Sep. 2023 ($168.34 Mil) to Dec. 2023 ($107.57 Mil).

Agilon Health's annual cash and cash equivalents declined from Dec. 2021 ($1,040.04 Mil) to Dec. 2022 ($465.30 Mil) and declined from Dec. 2022 ($465.30 Mil) to Dec. 2023 ($107.57 Mil).

Agilon Health Cash And Cash Equivalents Historical Data

The historical data trend for Agilon Health's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilon Health Cash And Cash Equivalents Chart

Agilon Health Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

123.63

106.80

1,040.04

465.30

107.57

Agilon Health Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial												465.30	394.19	190.98	168.34	107.57

Agilon Health Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Agilon Health (NYSE:AGL) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Agilon Health Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Agilon Health's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Agilon Health (Agilon Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Agilon Health Inc (NYSE:AGL) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

6210 E. US Highway 290, Suite 450, Austin, TX, USA, 78723

Website

https://www.agilonhealth.com

Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.

Executives

Jeffrey A. Schwaneke	director	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Steven Sell	director, officer: CEO & President	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Benjamin Shaker	officer: Chief Markets Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Timothy Gertsch	officer: Chief Accounting Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Silvana Battaglia	director	227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Cd&r Investment Associates Ix, Ltd.	10 percent owner	MAPLES CORPORATE SERVICES LIMITED, UGLAND HOUSE, GRAND CAYMAN E9 KY101194
Veeral Desai	officer: Chief Strategy & Dev. Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Benjamin Kornitzer	officer: Chief Med. & Quality Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
John William Wulf	director	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Diana Mckenzie	director	METLIFE, 200 PARK AVENUE, NEW YORK NY 10166
Priscilla Kasenchak	officer: Chief Accounting Officer	1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Michael L Smith	director	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Theodore Halkias	officer: Chief Business Officer	C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831
Joan Danieley	officer: Chief Administrative Officer	C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831
Glenn Sobotka	officer: Chief Accounting Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723